BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12518078)

  • 1. Methadone treatment in Ontario after the 1996 regulation reforms. Results of a physician survey.
    Fischer B; Cape D; Daniel N; Gliksman L
    Ann Med Interne (Paris); 2002 Nov; 153(7 Suppl):2S11-21. PubMed ID: 12518078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician peer assessments for compliance with methadone maintenance treatment guidelines.
    Strike C; Wenghofer E; Gnam W; Hillier W; Veldhuizen S; Millson M
    J Contin Educ Health Prof; 2007; 27(4):208-13. PubMed ID: 18085599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [General practitioner views on drug-assisted rehabilitation and the Norwegian substance abuse reform].
    Aasland OG; Spilhaug G; Johannesen A
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):97-100. PubMed ID: 19151800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation.
    Longman C; Lintzeris N; Temple-Smith M; Gilchrist G
    Drug Alcohol Rev; 2011 Jul; 30(4):355-9. PubMed ID: 21355929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of illegal opioid use and health services utilization in Canada.
    Popova S; Rehm J; Fischer B
    Public Health; 2006 Apr; 120(4):320-8. PubMed ID: 16476455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001.
    Strike CJ; Urbanoski K; Fischer B; Marsh DC; Millson M
    J Addict Dis; 2005; 24(1):39-51. PubMed ID: 15774409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study.
    Besson J; Beck T; Wiesbeck G; Hämmig R; Kuntz A; Abid S; Stohler R
    Swiss Med Wkly; 2014; 144():w13933. PubMed ID: 24706398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tighten Ontario's methadone program states inquest.
    Sibbald B
    CMAJ; 2005 Feb; 172(3):319-20. PubMed ID: 15684108
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing identification of and response to intimate partner violence: a survey of physicians and nurses.
    Gutmanis I; Beynon C; Tutty L; Wathen CN; MacMillan HL
    BMC Public Health; 2007 Jan; 7():12. PubMed ID: 17250771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
    Lawrinson P; Roche A; Terao H; Le PP
    Drug Alcohol Rev; 2008 Jan; 27(1):47-53. PubMed ID: 18034381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counseling regarding pregnancy--related drug exposures by family physicians in Ontario.
    Goodwin J; Rieder S; Rieder MJ; Matsui D
    Can J Clin Pharmacol; 2007; 14(1):e58-69. PubMed ID: 17314415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?
    Kurdyak P; Jacob B; Zaheer J; Fischer B
    Can Fam Physician; 2018 Feb; 64(2):e95-e103. PubMed ID: 29449263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing narcotics to habitual and addicted narcotic users. Medical and legal guidelines in California and some other Western states.
    Tennant FS; Uelmen GF
    West J Med; 1980 Dec; 133(6):539-45. PubMed ID: 7467311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased caseloads in methadone treatment programs: implications for the delivery of services and retention in treatment.
    Stewart D; Gossop M; Marsden J
    J Subst Abuse Treat; 2004 Dec; 27(4):301-6. PubMed ID: 15610831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.